STADA Arzneimittel AG
SAZ | HM
Overview
Corporate Details
- ISIN(s):
- DE0007251803 (+1 more)
- LEI:
- 529900FMTTLMH0P0DL10
- Country:
- Germany
- Address:
- Stadastraße 2 - 18, 61118 Bad Vilbel
- Website:
- https://www.stada.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for more than 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally. STADA focuses on a three pillar strategy consisting of generics, specialty pharma and non-prescription consumer healthcare products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. Consumer Healthcare brands such as Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® and Nizoral® are among the top sellers in their respective product categories.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-07 00:00 |
Declaration of Voting Results & Voting Rights Announcements
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
|
German | 5.6 KB | |
| 2025-02-04 00:00 |
Annual Audited Financial Statements
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 564.0 KB | |
| 2025-01-21 00:00 |
Annual Report
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 1.8 MB | |
| 2024-02-14 00:00 |
Regulatory News Service
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 536.7 KB | |
| 2024-01-10 00:00 |
Regulatory News Service
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 1.5 MB | |
| 2023-02-23 14:15 |
Report Publication Announcement
|
English | 3.9 KB | |
| 2023-02-23 11:25 |
Report Publication Announcement
|
English | 4.0 KB | |
| 2023-02-23 00:00 |
Report Publication Announcement
Hinweis auf Jahresfinanzbericht vom 01.01.2022 bis zum 31.12.2022
|
German | 5.7 KB | |
| 2023-02-23 00:00 |
Report Publication Announcement
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
|
German | 5.7 KB | |
| 2023-02-23 00:00 |
Report Publication Announcement
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
|
German | 5.7 KB | |
| 2023-02-23 00:00 |
Report Publication Announcement
Hinweis auf Jahresfinanzbericht vom 01.01.2022 bis zum 31.12.2022
|
German | 5.7 KB | |
| 2022-09-27 00:00 |
Annual Audited Financial Statements
Ergänzung der Veröffentlichung vom 12.04.2022
|
German | 2.2 KB | |
| 2022-08-17 09:49 |
Report Publication Announcement
|
English | 4.0 KB | |
| 2022-08-17 00:00 |
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
|
German | 5.7 KB | |
| 2022-08-17 00:00 |
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
|
German | 5.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
Antibiotice S.A. | Romania | ATB |